1. Home
  2. WEST vs NUVB Comparison

WEST vs NUVB Comparison

Compare WEST & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WEST
  • NUVB
  • Stock Information
  • Founded
  • WEST 2009
  • NUVB 2018
  • Country
  • WEST United States
  • NUVB United States
  • Employees
  • WEST N/A
  • NUVB N/A
  • Industry
  • WEST Beverages (Production/Distribution)
  • NUVB Biotechnology: Pharmaceutical Preparations
  • Sector
  • WEST Consumer Staples
  • NUVB Health Care
  • Exchange
  • WEST Nasdaq
  • NUVB Nasdaq
  • Market Cap
  • WEST 640.7M
  • NUVB 679.9M
  • IPO Year
  • WEST N/A
  • NUVB N/A
  • Fundamental
  • Price
  • WEST $6.26
  • NUVB $2.38
  • Analyst Decision
  • WEST Strong Buy
  • NUVB Strong Buy
  • Analyst Count
  • WEST 5
  • NUVB 6
  • Target Price
  • WEST $10.60
  • NUVB $7.83
  • AVG Volume (30 Days)
  • WEST 273.1K
  • NUVB 9.3M
  • Earning Date
  • WEST 08-07-2025
  • NUVB 08-04-2025
  • Dividend Yield
  • WEST N/A
  • NUVB N/A
  • EPS Growth
  • WEST N/A
  • NUVB N/A
  • EPS
  • WEST N/A
  • NUVB N/A
  • Revenue
  • WEST $872,022,000.00
  • NUVB $10,957,000.00
  • Revenue This Year
  • WEST $22.72
  • NUVB $101.21
  • Revenue Next Year
  • WEST $14.75
  • NUVB $410.28
  • P/E Ratio
  • WEST N/A
  • NUVB N/A
  • Revenue Growth
  • WEST 2.38
  • NUVB N/A
  • 52 Week Low
  • WEST $5.28
  • NUVB $1.54
  • 52 Week High
  • WEST $10.17
  • NUVB $3.97
  • Technical
  • Relative Strength Index (RSI)
  • WEST 47.75
  • NUVB 55.57
  • Support Level
  • WEST $5.65
  • NUVB $2.03
  • Resistance Level
  • WEST $6.54
  • NUVB $2.15
  • Average True Range (ATR)
  • WEST 0.28
  • NUVB 0.14
  • MACD
  • WEST 0.04
  • NUVB 0.03
  • Stochastic Oscillator
  • WEST 61.81
  • NUVB 85.22

About WEST Westrock Coffee Company

Westrock Coffee Co is an integrated coffee, tea, flavors, extracts, and ingredients solutions provider in the U.S, providing coffee sourcing, supply chain management, product development, roasting, packaging, and distribution services to retail, foodservice and restaurant, convenience store and travel center, non-commercial account, CPG, and hospitality industries around the world. The company's segment includes Beverage Solutions and Sustainable Sourcing and Traceability. It generates maximum revenue from the Beverage Solutions segment.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).

Share on Social Networks: